Clinical Trial Update: BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling [Phase 1]

View source ↗

Summary

The BELIEVE study, a Phase 1 trial evaluating nesiritide for post-myocardial infarction left ventricular modeling, sponsored by Mayo Clinic, has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: Mayo Clinic | Conditions: Myocardial Infarction | Phase 1 | Status: TERMINATED